320 related articles for article (PubMed ID: 30219676)
1. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of the Warburg effect increases the sensitivity of cancer cells to TRAIL-induced cell death.
Kumazaki M; Shinohara H; Taniguchi K; Takai T; Kuranaga Y; Sugito N; Akao Y
Exp Cell Res; 2016 Sep; 347(1):133-142. PubMed ID: 27453209
[TBL] [Abstract][Full Text] [Related]
4. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
5. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.
Caruso P; Dunmore BJ; Schlosser K; Schoors S; Dos Santos C; Perez-Iratxeta C; Lavoie JR; Zhang H; Long L; Flockton AR; Frid MG; Upton PD; D'Alessandro A; Hadinnapola C; Kiskin FN; Taha M; Hurst LA; Ormiston ML; Hata A; Stenmark KR; Carmeliet P; Stewart DJ; Morrell NW
Circulation; 2017 Dec; 136(25):2451-2467. PubMed ID: 28971999
[TBL] [Abstract][Full Text] [Related]
6. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract][Full Text] [Related]
7. Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells.
Wu H; Cui M; Li C; Li H; Dai Y; Cui K; Li Z
J Agric Food Chem; 2021 Mar; 69(10):3060-3068. PubMed ID: 33663206
[TBL] [Abstract][Full Text] [Related]
8. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract][Full Text] [Related]
9. PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.
Taniguchi K; Sakai M; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakayama T; Ueda H; Nakagawa Y; Ito Y; Futamura M; Uno B; Otsuki Y; Yoshida K; Uchiyama K; Akao Y
Oncotarget; 2016 Apr; 7(14):18940-52. PubMed ID: 26980745
[TBL] [Abstract][Full Text] [Related]
10. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.
Sugiyama T; Taniguchi K; Matsuhashi N; Tajirika T; Futamura M; Takai T; Akao Y; Yoshida K
Cancer Sci; 2016 Dec; 107(12):1767-1775. PubMed ID: 27696637
[TBL] [Abstract][Full Text] [Related]
11. A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio.
Li Y; Chen X; Huang H; Liao L; Chong H; Li G; Yuan T; Lu W; Deng S; Huang Q
Cancer Sci; 2023 Apr; 114(4):1519-1540. PubMed ID: 36529521
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis.
Wu H; Du J; Li C; Li H; Guo H; Li Z
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408903
[TBL] [Abstract][Full Text] [Related]
13. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor ELK1 accelerates aerobic glycolysis to enhance osteosarcoma chemoresistance through miR-134/PTBP1 signaling cascade.
Zhang Q; Wu J; Zhang X; Cao L; Wu Y; Miao X
Aging (Albany NY); 2021 Feb; 13(5):6804-6819. PubMed ID: 33621196
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
16. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
[TBL] [Abstract][Full Text] [Related]
17. PTBP1 promotes tumorigenesis by regulating apoptosis and cell cycle in colon cancer.
Li X; Han F; Liu W; Shi X
Bull Cancer; 2018 Dec; 105(12):1193-1201. PubMed ID: 30309622
[TBL] [Abstract][Full Text] [Related]
18. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.
Calabretta S; Bielli P; Passacantilli I; Pilozzi E; Fendrich V; Capurso G; Fave GD; Sette C
Oncogene; 2016 Apr; 35(16):2031-9. PubMed ID: 26234680
[TBL] [Abstract][Full Text] [Related]
19. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK.
Yu M; Xu C; Zhang H; Lun J; Wang L; Zhang G; Fang J
Biochem Biophys Res Commun; 2021 Jul; 563():1-7. PubMed ID: 34052504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
